Abstract:The present study describes the synthesis and biological evaluation of In-111(DOTA-3P-RGD(2)) (DOTA = 1,4,7,10-tetraazacyclo-dodecane-1,4,7,10-tetraacetic acid; 3P-RGD(2) = PEG(4)-E[PEG(4)-c(RGDfK)](2); PEG(4) = 15-amino-4,7,10,13-tetraoxapentadecanoic acid), In-111(DTPA-3P-RGD(2)) (DTPA = diethylenetriaminepentaacetic acid) and In-111(DTPA-Bn-3P-RGD(2)) (DTPA-Bn = 2-(p-thioureidobenzyl)-diethylenetriaminepentaacetic acid) as potential radiotracers for imaging tumor integrin alpha(v)beta(3) expression in athymic nude mice bearing U87MG glioma xenografts. The aim of the study is to assess the impact of the bifunctional chelator (BFC) (DOTA vs. DTPA or DTPA-Bn) on the biodistribution characteristics of the In-111-labeled 3P-RGD(2). IC50 values of DOTA-3P-RGD(2), DTPA-3P-RGD(2) and DTPA-Bn-3P-RGD(2) were determined to be 1.3 +/- A 0.2, 1.4 +/- A 0.3, 1.3 +/- A 0.3 nM, respectively, against I-125-c(RGDyK) bound to U87MG human glioma cells. Radiotracers were prepared by reacting (InCl3)-In-111 with the RGD peptide conjugates in NH4OAc buffer (100 mM, pH 5.5). For DOTA-3P-RGD(2), successful radiolabeling could be completed by heating the reaction mixture at 100A degrees C for 15-20 min. For DTPA-3P-RGD(2) and DTPA-Bn-3P-RGD(2), the radiolabeling was almost instantaneous at room temperature. The specific activity was similar to 50 mCi/mg (or similar to 100 mCi/mu mol) for In-111(DOTA-3P-RGD(2)) and similar to 200 mCi/mg (or similar to 400 mCi/mu mol) for In-111(DTPA-3P-RGD(2)). The results from biodistribution studies showed that all the three radiotracers have high tumor uptake and excellent tumor-to-background (T/B) ratios up to 4-h postinjection. After that time point, both In-111(DTPA-3P-RGD(2)) and In-111(DTPA-Bn-3P-RGD(2)) showed a much faster tumor washout and poorer T/B ratios than In-111(DOTA-3P-RGD(2)). The tumor uptake of In-111(DOTA-3P-RGD(2)) is integrin alpha(v)beta(3)- and RGD-specific. In-111(DOTA-3P-RGD(2)) is metabolically stable while only similar to 25% of In-111(DTPA-Bn-3P-RGD(2)) remains intact in the feces during 2-h period. On the basis of results from this study, it was concluded that In-111(DTPA-3P-RGD(2)) can be an effective integrin alpha(v)beta(3)-targeted radiotracer if the high-specific activity is required. However, DOTA remains to be the BFC of choice for the development of therapeutic lanthanide radiotracers.

A Novel Bifunctional Chelating Agent for Tyrosine-Specific Radiolabeling of Peptides and Proteins

A new 18F-RBF3 radioprosthetic for one step aqueous labeling of peptides and other ligands: meeting the challenge of radiosynthetic ease and preclinical impact i.e. high specific activity and high T:NT ratios

Chelator-free synthesis of a dual-modality PET/MRI agent

Impact Of Bifunctional Chelators On Biological Properties Of In-111-Labeled Cyclic Peptide Rgd Dimers

A NEW BIFUNCTIONAL CHELATING AGENT Α,ε-N,n'-bis(l-cysteinyl)-l-lysine FOR RADIOLABELLING OF MONOCLONAL ANTIBODIES WITH TECHNETIUM-99M

Radioiodination of BODIPY and Its Application to a Nuclear and Optical Dual Functional Labeling Agent for Proteins and Peptides

New Peptide Labeling Technique Based on Bifunctional Reagent and Rare Earth Metal Chelating Tags

PYTA: a universal chelator for advancing the theranostic palette of nuclear medicine

eTFC-01: a dual-labeled chelate-bridged tracer for SSTR2-positive tumors

Synthesis of Site-Specific Radiolabeled Antibodies for Radioimmunotherapy Via Genetic Code Expansion.

Labeling Monoclonal-Antibodies with Yttrium-90-Dota and Indium-111-Dota Chelates - A Simple and Efficient Method

Kit-like 18F-labeling of RGD-19F-arytrifluroborate in high yield and at extraordinarily high specific activity with preliminary in vivo tumor imaging.

A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements

Recent advances in the development of 225Ac- and 211At-labeled radioligands for radiotheranostics

Exploration of 68Ga-DOTA-MAL as a Versatile Vehicle for Facile Labeling of a Variety of Thiol-Containing Bioactive Molecules

Organomediated Cleavage of Benzoyl Group Enables an Efficient Synthesis of 1-(6-nitropyridin-2-yl)thiourea and Its Application for Developing 18F-Labeled PET Tracers.

Impact of Bifunctional Chelators on Biological Properties of 111In-Labeled Cyclic Peptide RGD Dimers

Potential Therapeutic Radiotracers: Preparation, Biodistribution and Metabolic Characteristics of 177 Lu-labeled Cyclic RGDfK Dimer

Triazine-pyridine Chemistry for Protein Labelling on Tyrosine

"Off‐Label" Use of Enterobactin Enables Targeted Imaging of Cancer with Radioactive Ti(IV)

Combination of the amide-to-triazole substitution strategy with alternative structural modifications for the metabolic stabilization of tumor-targeting, radiolabeled peptides